These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35744731)

  • 1. Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France.
    Bonnet I; Haddad E; Guglielmetti L; Bémer P; Bernard L; Bourgoin A; Brault R; Catho G; Caumes E; Escaut L; Fourniols E; Fréchet-Jachym M; Gaudart A; Guillot H; Lafon-Desmurs B; Lanoix JP; Lanotte P; Lemaignen A; Lemaire B; Lemaitre N; Michau C; Morand P; Mougari F; Marigot-Outtandy D; Patrat-Delon S; Perpoint T; Piau C; Pourcher V; Zarrouk V; Zeller V; Veziris N; Jauréguiberry S; Aubry A;
    Microorganisms; 2022 Jun; 10(6):. PubMed ID: 35744731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.
    Guglielmetti L; Jaffré J; Bernard C; Brossier F; El Helali N; Chadelat K; Thouvenin G; Dautzenberg B; Henry B; Jaspard M; Guillot H; Pourcher V; Le Dû D; Marigot-Outtandy D; Mougari F; Raskine L; Rivoire B; Andrejak C; Jarlier V; Aubry A; Robert J; Frechet-Jachym M; Veziris N
    Int J Tuberc Lung Dis; 2019 Oct; 23(10):1050-1054. PubMed ID: 31627768
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of multidrug-resistant tuberculosis in Thailand.
    Maranetra KN
    Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.
    Kherabi Y; Fréchet-Jachym M; Rioux C; Yazdanpanah Y; Méchaï F; Pourcher V; Robert J; Guglielmetti L;
    Emerg Infect Dis; 2022 Sep; 28(9):1796-1804. PubMed ID: 35997386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
    Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
    BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.
    Pai H; Ndjeka N; Mbuagbaw L; Kaniga K; Birmingham E; Mao G; Alquier L; Davis K; Bodard A; Williams A; Van Tongel M; Thoret-Bauchet F; Omar SV; Bakare N
    BMC Infect Dis; 2022 Nov; 22(1):870. PubMed ID: 36414938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
    Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
    Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
    PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment efficacy of drug-resistant tuberculosis in Bashkortostan, Russia: A retrospective cohort study.
    Yunusbaeva M; Borodina L; Alekseev P; Davydov R; Yunusbaev U; Sharipov R; Bilalov F; Yunusbayev B
    Int J Infect Dis; 2019 Apr; 81():203-209. PubMed ID: 30794942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcome of multidrug-resistant tuberculosis in a low-incidence area.
    Gaborit BJ; Revest M; Roblot F; Maakaroun-Vermesse Z; Bemer P; Guimard T; Raffi F; Bourigault C; Boutoille D;
    Med Mal Infect; 2018 Oct; 48(7):457-464. PubMed ID: 29887187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study.
    Riccardi N; Saderi L; Borroni E; Tagliani E; Cirillo DM; Marchese V; Matteelli A; Piana A; Castellotti P; Ferrarese M; Gualano G; Palmieri F; Girardi E; Codecasa L; Sotgiu G
    Int J Tuberc Lung Dis; 2021 May; 25(5):395-399. PubMed ID: 33977908
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term treatment outcomes in patients with multidrug-resistant tuberculosis.
    Maier C; Chesov D; Schaub D; Kalsdorf B; Andres S; Friesen I; Reimann M; Lange C
    Clin Microbiol Infect; 2023 Jun; 29(6):751-757. PubMed ID: 36842637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Resistant Bone, Joint and Spine Tuberculosis: Evolution of Diagnosis and Treatment.
    Jain AK; Jain P; Jaggi K; Suresh A; Yadav M; Gain A; Gupta H
    Indian J Orthop; 2024 Jun; 58(6):661-668. PubMed ID: 38812873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 20-year retrospective study of osteoarticular tuberculosis in a pediatric third level referral center.
    González Saldaña N; Macías Parra M; Xochihua Díaz L; Palavicini Rueda M; Carmona Vargas AJ; Castillo Bejarano JI; Veloz Corona Q; Juárez Olguín H; Chavez Pacheco JL
    BMC Pulm Med; 2021 Aug; 21(1):265. PubMed ID: 34399724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoarticular tuberculosis in Central India: Changing epidemiological profile and emerging challenges.
    Kori VK; Bandil D; Asthana M; Maravi DS
    Int J Mycobacteriol; 2023; 12(1):28-32. PubMed ID: 36926759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013-2018.
    McDowell A; Haas M; Seaworth B; Wilson JW; Patrawalla A; Haley C; Lauzardo M; de Bruyn M; Goswami ND
    J Clin Tuberc Other Mycobact Dis; 2021 Feb; 22():100201. PubMed ID: 33336084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.